Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
LIPOLipella Pharmaceuticals Inc.
| Figure | LIPOLipella Pharmaceuticals Inc.FY2024 · Dec |
|---|---|
| Revenue | $536.36K |
| Revenue, yoy | +19.3% |
| Net income | $5.02M |
| Net income, yoy | −8.6% |
| Net margin | -935.2% |
| Free cash flow | $3.16M |
| FCF margin | — |
| EPS, diluted | $4.79 |
Add another company.
Annual · FY2021–FY2024 · USD
From SEC EDGARSame fiscal periods, as filed